Skip to main content

Bleeding and Thrombosis in the ICU

  • Chapter
  • First Online:
Adult Critical Care Medicine
  • 2148 Accesses

Abstract

Patients in the critical care unit are at high risk for both bleeding and thrombosis. Common contributors to bleeding are liver disease, thrombocytopenia, disseminated intravascular coagulation, hemodilution, and antithrombotic drugs. Routine laboratory investigations can help to understand the contributing factors in a given patient. Mainstays of therapy are coagulation factor replacement, primarily with plasma, and platelet transfusion. Contributors to the risk of thrombosis include immobility, trauma, inflammation/stress response, indwelling catheters, and both bleeding and transfusion. Management of thrombosis is challenging, requiring one to balance risks of progressive thrombosis versus hemorrhage. Unfractionated heparin still has a role in this setting, as do IVC filters in carefully selected patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Thachil J. Disseminated intravascular coagulation: a practical approach. Anesthesiology. 2016;125(1):230–6.

    Article  Google Scholar 

  2. Zarychanski R, Houston DS. Assessing thrombocytopenia in the intensive care unit: the past, present, and future. Hematology Am Soc Hematol Educ Program. 2017;2017(1):660–6.

    PubMed  Google Scholar 

  3. Menard CE, Kumar A, Rimmer E, Doucette S. A.F. T, Houston BL, et al. evolution & impact of thrombocytopenia in septic shock. Intens Care Med Exp. 2016;4(Suppl 1):A586.

    Google Scholar 

  4. Wikkelso A, Wetterslev J, Moller AM, Afshari A. Thromboelastography (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding. Cochrane Database Syst Rev. 2016;8:CD007871.

    Google Scholar 

  5. Takemitsu T, Wada H, Hatada T, Ohmori Y, Ishikura K, Takeda T, et al. Prospective evaluation of three different diagnostic criteria for disseminated intravascular coagulation. Thromb Haemost. 2011;105(1):40–4.

    Article  CAS  Google Scholar 

  6. McDaniel LM, Etchill EW, Raval JS, Neal MD. State of the art: massive transfusion. Transfus Med. 2014;24(3):138–44.

    Article  CAS  Google Scholar 

  7. Simpson E, Lin Y, Stanworth S, Birchall J, Doree C, Hyde C. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database Syst Rev. 2012;3:CD005011.

    Google Scholar 

  8. Kaufman RM, Djulbegovic B, Gernsheimer T, Kleinman S, Tinmouth AT, Capocelli KE, et al. Platelet transfusion: a clinical practice guideline from the AABB. Ann Intern Med. 2015;162(3):205–13.

    Article  Google Scholar 

  9. Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving Sepsis campaign: international guidelines for Management of Sepsis and Septic Shock: 2016. Crit Care Med. 2017;45(3):486–552.

    Article  Google Scholar 

  10. Cook D, Meade M, Guyatt G, Walter S, Heels-Ansdell D, Warkentin TE, et al. Dalteparin versus unfractionated heparin in critically ill patients. N Engl J Med. 2011;364(14):1305–14.

    Article  CAS  Google Scholar 

  11. Cook DJ, Crowther MA, Meade MO, Douketis J, VTEitIW P. Prevalence, incidence, and risk factors for venous thromboembolism in medical-surgical intensive care unit patients. J Crit Care. 2005;20(4):309–13.

    Article  Google Scholar 

  12. Lim W, Meade M, Lauzier F, Zarychanski R, Mehta S, Lamontagne F, et al. Failure of anticoagulant thromboprophylaxis: risk factors in medical-surgical critically ill patients*. Crit Care Med. 2015;43(2):401–10.

    Article  CAS  Google Scholar 

  13. Warkentin TE. Heparin-induced thrombocytopenia in critically ill patients. Semin Thromb Hemost. 2015;41(1):49–60.

    Article  CAS  Google Scholar 

  14. Lo GK, Juhl D, Warkentin TE, Sigouin CS, Eichler P, Greinacher A. Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost. 2006;4(4):759–65.

    Article  CAS  Google Scholar 

  15. De Paepe P, Belpaire FM, Buylaert WA. Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock. Clin Pharmacokinet. 2002;41(14):1135–51.

    Article  Google Scholar 

  16. Duffett L, Carrier M. Inferior vena cava filters. J Thromb Haemost. 2017;15(1):3–12.

    Article  CAS  Google Scholar 

  17. Marshall PS, Mathews KS, Siegel MD. Diagnosis and management of life-threatening pulmonary embolism. J Intensive Care Med. 2011;26(5):275–94.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ryan Zarychanski .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Houston, D.S., Zarychanski, R. (2019). Bleeding and Thrombosis in the ICU. In: LaRosa, J. (eds) Adult Critical Care Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-94424-1_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-94424-1_16

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-94423-4

  • Online ISBN: 978-3-319-94424-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics